Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction

ISSN： 1420-682X

Source： Cellular and Molecular Life Sciences CMLS, Vol.63, Iss.15, 2006-08, pp. : 1725-1735

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical and molecular characterization of Rubinstein‐Taybi syndrome patients carrying distinct novel mutations of the EP300 gene

CLINICAL GENETICS, Vol. 87, Iss. 2, 2015-02 ,pp. : 148-154

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insights into genotype–phenotype correlations from CREBBP point mutation screening in a cohort of 46 Rubinstein–Taybi syndrome patients

CLINICAL GENETICS, Vol. 9-9163, Iss. 5, 2015-11 ,pp. : 431-440

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insights into genotype–phenotype correlations from CREBBP point mutation screening in a cohort of 46 Rubinstein–Taybi syndrome patients

CLINICAL GENETICS, Vol. 88, Iss. 5, 2015-11 ,pp. : 431-440

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Approaches to Improve the Insecticidal Activity of Bacillus thuringiensis Cry Toxins

By Lucena Wagner A. Pelegrini Patrícia B. Martins-de-Sa Diogo Fonseca Fernando C. A. Gomes Jose E. de Macedo Leonardo L. P. da Silva Maria Cristina M. Oliveira Raquel S. Grossi-de-Sa Maria F.

Toxins, Vol. 6, Iss. 8, 2014-08 ,pp. : 2393-2423

MDPI

Access to resources Recommend Favorite

Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype–Phenotype Correlations

HUMAN MUTATION, Vol. 36, Iss. 9, 2015-09 ,pp. : 881-893

John Wiley & Sons Inc

Access to resources Recommend Favorite